Review
Published on 25 Sep 2024
Hydrogel-based formulations for urothelial cancer therapy
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1478394
- 693 views
Type at least 3 characters
920 articles
Articles
Editorial
Published on 20 Sep 2024
Editorial: Molecular targets in oncological and hematological disease management: innovations in precision medicine
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1494396
- 248 views
Original Research
Published on 20 Sep 2024
A quantitative systems pharmacology (QSP) platform for preclinical to clinical translation of in-vivo CRISPR-Cas therapy
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1454785
- 1,479 views
Original Research
Published on 19 Sep 2024
Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1443988
- 527 views
Original Research
Published on 04 Sep 2024
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1457363
- 2,067 views
Original Research
Published on 02 Sep 2024
Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1440985
- 1,019 views
Original Research
Published on 30 Aug 2024
The epigenetic signatures of opioid addiction and physical dependence are prevented by D-cysteine ethyl ester and betaine
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1416701
- 765 views
Review
Published on 28 Aug 2024
Advances in research on potential therapeutic approaches for Niemann-Pick C1 disease
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1465872
- 906 views
Clinical Trial
Published on 22 Aug 2024
Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1433587
- 943 views
Original Research
Published on 20 Aug 2024
In vitro evidence of antioxidant and anti-inflammatory effects of a new nutraceutical formulation explains benefits in a clinical setting of COPD patients
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1439835
- 739 views
Original Research
Published on 16 Aug 2024
The GLP-1 receptor agonist exendin-4 reduces taurine and glycine in nucleus accumbens of male rats, an effect tentatively involving the nucleus tractus solitarius
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1439203
- 978 views
Original Research
Published on 12 Aug 2024
The integrated analysis of gut microbiota and metabolome revealed steroid hormone biosynthesis is a critical pathway in liver regeneration after 2/3 partial hepatectomy
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1407401
- 995 views
Clinical Trial
Published on 12 Aug 2024
No QTc prolongation with CDK 4/6 inhibitor FCN-437c: results of a concentration-QTc analysis from a dedicated study in adult healthy subjects
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1433663
- 763 views
Review
Published on 05 Aug 2024
Impact of p53-associated acute myeloid leukemia hallmarks on metabolism and the immune environment
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1409210
- 2,030 views
Perspective
Published on 02 Aug 2024
Artificial intelligence integration in the drug lifecycle and in regulatory science: policy implications, challenges and opportunities
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1437167
- 2,167 views
Editorial
Published on 30 Jul 2024
Editorial: Pharmacoinformatics: new developments and challenges in drug design
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1462070
- 701 views